Recent evidence has shown that the combination of insulin with GLP1R agonist, provided a similar reduction of HbA1c to a “basal-plus” or a “full basal-bolus” insulin regimen while inferring reduced hypoglycemia and body weight [8,9]. This evidence concerns the gene INS and Hypoglycemia.